S100A9 and acute promyelocytic leukemia: In APL, upon treatment with all-trans retinoic acid (ATRA) and, to a lesser degree, with As2O3, S100A9 expression levels increase but also seem to have increased sensitivity to treatment through a pro-apoptotic impact.